{"title":"Contrasting emerging tomato viruses: global impact of tomato brown rugose fruit virus and the uncertain threat of tomato fruit blotch virus.","authors":"Nida' Salem, Motasem Abumuslem, Marina Ciuffo, Massimo Turina","doi":"10.1016/j.coviro.2026.101592","DOIUrl":"https://doi.org/10.1016/j.coviro.2026.101592","url":null,"abstract":"<p><p>This review examines two recently emerged tomato viruses that exemplify contrasting biological and epidemiological paradigms. Tomato brown rugose fruit virus (ToBRFV) belongs to the genus Tobamovirus, within one of the most extensively studied plant virus families (Virgaviridae). Despite this deep knowledge base, ToBRFV has caused unprecedented global economic disruption because of the lack of efficacy of the long‑standing and widely deployed Tm‑2² resistance gene, historically considered durable against tobamoviruses. Its rapid global spread, highly efficient mechanical transmissibility, environmental persistence, and severe impact on fruit quality have challenged established disease management strategies and highlighted critical gaps in resistance durability. In contrast, tomato fruit blotch virus (ToFBV), a member of the relatively recently established genus Blunervirus (family Kitaviridae), represents an emerging and still poorly understood group of plant viruses. Transmitted by eriophyid mites, ToFBV displays atypical biological features, including limited systemic movement, variable symptom expression, and dependence on vector dynamics. By comparing these two pathogens, this review highlights how both well‑characterized and newly emergent virus groups can pose significant and distinct challenges to global tomato production.</p>","PeriodicalId":11082,"journal":{"name":"Current opinion in virology","volume":"77 ","pages":"101592"},"PeriodicalIF":5.5,"publicationDate":"2026-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149402929","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"How vaccine platforms are shaping preparedness for emerging and re-emerging viruses alike.","authors":"Daniel M Jones, Sarah C Gilbert","doi":"10.1016/j.coviro.2026.101595","DOIUrl":"https://doi.org/10.1016/j.coviro.2026.101595","url":null,"abstract":"<p><p>Vaccine platforms are validated, adaptable technologies designed to enable a 'plug-and-play' approach to vaccine development and deployment, and have emerged as a cornerstone for epidemic and pandemic preparedness due to their capacity to be rapidly tailored to emerging pathogens. This capability was demonstrated during the COVID-19 pandemic, when the first clinical trial of a SARS-CoV-2 vaccine was initiated just 66 days after the viral genome was published. However, outbreaks caused by novel emerging viruses like SARS-CoV-2 are less common than those caused by known, re-emerging pathogens, including Marburg, Nipah and Lassa viruses. Unlike SARS-CoV-2, these pathogens have been recognised as public health threats for decades, yet licensed vaccines against them have yet to be realised. While this gap is partly attributable to scientific shortfalls, a more significant factor has arguably been the combination of economic, regulatory and epidemiological challenges that have impeded vaccine licensure and stockpile establishment. This review discusses how vaccine platforms are addressing some of these challenges, potentially providing the foundation for much-needed vaccine stockpiling approaches against re-emerging pathogens.</p>","PeriodicalId":11082,"journal":{"name":"Current opinion in virology","volume":"77 ","pages":"101595"},"PeriodicalIF":5.5,"publicationDate":"2026-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149402930","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Joshua A Hayward , Michelle L Baker , Gilda Tachedjian
{"title":"Antiviral restriction factors of bats: the front line of a critical reservoir of zoonotic viruses","authors":"Joshua A Hayward , Michelle L Baker , Gilda Tachedjian","doi":"10.1016/j.coviro.2026.101522","DOIUrl":"10.1016/j.coviro.2026.101522","url":null,"abstract":"<div><div>Bats harbor diverse viruses pathogenic in other mammals, typically without obvious signs of clinical disease, attributed to an immune system that balances antiviral immunity with disease tolerance. It has been hypothesized that this balanced immune system may have arisen, at least in part, in response to the evolution of flight, which generates cellular stress, and subsequent selection for reduced inflammation and disease tolerance in bats. A major component of antiviral immunity is restriction factors (RFs). RFs are host cell proteins representing the first line of antiviral defense in all mammals, including bats. Here, we review recent advances in our understanding of bat RFs that have diversified compared to many of their counterparts in humans and other mammals. Across bat lineages, RF repertoires are repeatedly remodeled through shifts in basal and interferon-stimulated gene expression and expansions (e.g. <em>APOBEC3, TRIM, IFITM, tetherin, GBPs</em>). These diversified RFs target all major stages of viral replication. Bat-specific variations in RFs include residue- and isoform-dependent IFITM3 and tetherin functions, extensive <em>APOBEC3</em> and <em>TRIM</em> gene locus rearrangements, as well as the presence of novel RFs, including a yet-to-be-identified RF that functions as a dominant, capsid-dependent nuclear-import block in pteropids, and RTP4 and RNF214 present in both bats and humans. Understanding these bat-adapted antiviral factors may inspire new approaches for host-directed therapeutics.</div></div>","PeriodicalId":11082,"journal":{"name":"Current opinion in virology","volume":"75 ","pages":"Article 101522"},"PeriodicalIF":5.1,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147590716","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Inborn errors of autophagy underlying severe viral infections in humans","authors":"Trine H Mogensen","doi":"10.1016/j.coviro.2026.101510","DOIUrl":"10.1016/j.coviro.2026.101510","url":null,"abstract":"<div><div>Inborn errors of immunity can underlie susceptibility to severe viral infection in humans. and the majority relate to defective induction of or response to antiviral type I interferon (IFN). However there is increasing awareness of defects in other cellular processes, that can predispose to severe infectious disease. Recently, defects in autophagy-related genes or -processes have been demonstrated to predispose to life-threatening viral diseases, including defects in autophagy-related genes in patients with herpes simplex virus and varicella zoster virus infections in the central nervous system, as well as impairment of noncanonical antiviral immunity in critical COVID-19. However, the molecular mechanisms and complex intersections between autophagy, metabolism, cell death, and inflammation, and how defects in autophagy-related proteins may interfere with these cellular processes, are only now starting to emerge. This review presents the current knowledge on inborn errors of autophagy discovered in patients with severe viral infection and discusses some of the remaining knowledge gaps in our understanding of how autophagy processes act against viruses, how immunopathology and lack of viral control ensues when they fail, and how these insights may be translated into clinical medicine.</div></div>","PeriodicalId":11082,"journal":{"name":"Current opinion in virology","volume":"75 ","pages":"Article 101510"},"PeriodicalIF":5.1,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146077278","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Orthobunyavirus entry: receptors, endocytosis, and fusion cues","authors":"Qilin Xin , Pierre-Yves Lozach","doi":"10.1016/j.coviro.2026.101523","DOIUrl":"10.1016/j.coviro.2026.101523","url":null,"abstract":"<div><div>Orthobunyaviruses (OBVs) are medically and veterinary important arboviruses with simple genomes yet complex entry mechanisms enabling infection of diverse mammalian hosts. Understanding of the molecular and cellular processes mediating OBV attachment, internalization, endosomal trafficking, and membrane fusion has advanced recently. Here, we review how OBVs engage host receptors, notably the low-density lipoprotein receptor-related protein 1 (Lrp1), utilize clathrin-mediated endocytosis, and respond to endosomal acidification and potassium ion accumulation to trigger fusion via their class II Gc glycoprotein. Live-cell imaging has elucidated single-particle entry dynamics, revealing the interplay of viral and host factors in timing and efficiency of genome release. These findings refine the model of OBV entry, highlighting coordinated physicochemical cues and receptor usage that influence tropism and pathogenesis. Improved mechanistic insights offer potential avenues for broad-spectrum antiviral development and enhance understanding of OBV epidemiology, exemplified by Oropouche virus emergence in South America.</div></div>","PeriodicalId":11082,"journal":{"name":"Current opinion in virology","volume":"75 ","pages":"Article 101523"},"PeriodicalIF":5.1,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147590791","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Beyond the liver: the broadened tissue tropism of hepatitis E virus","authors":"Sarah Schlienkamp , Olinda Pinto Veiga , Volker Kinast , Eike Steinmann","doi":"10.1016/j.coviro.2025.101508","DOIUrl":"10.1016/j.coviro.2025.101508","url":null,"abstract":"<div><div>Hepatitis E virus (HEV) is a leading cause of acute viral hepatitis, yet the virus has been associated with extrahepatic complications, including neurological and renal disorders. These extrahepatic manifestations pose challenges for the diagnosis and treatment of HEV and are considered a reservoir for disease relapse. In addition to recent <em>in vivo</em> patient data, several animal and <em>in vitro</em> models have been established in the last few years, confirming the broad HEV tissue tropism. However, it remains unclear whether extrahepatic complications arise from viral replication within the tissue or from immune-mediated effects. This article highlights current knowledge on the detection of HEV in extrahepatic tissues, with a focus on active HEV replication in humans and animal models.</div></div>","PeriodicalId":11082,"journal":{"name":"Current opinion in virology","volume":"74 ","pages":"Article 101508"},"PeriodicalIF":5.1,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145920685","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Juwan Kim , Su J Lee , Dae-Gyun Ahn , Ji-Seung Yoo
{"title":"Immune evasion and pathogenesis of henipaviruses","authors":"Juwan Kim , Su J Lee , Dae-Gyun Ahn , Ji-Seung Yoo","doi":"10.1016/j.coviro.2026.101509","DOIUrl":"10.1016/j.coviro.2026.101509","url":null,"abstract":"<div><div>Zoonotic viruses pose an escalating threat to global health, driven by climate change, deforestation, urbanization, and increased human-wildlife interactions. Among these threats, Henipaviruses — particularly Hendra virus and Nipah virus — have emerged as priority pathogens due to their severe clinical manifestations, broad host range, and pandemic potential. Naturally maintained in asymptomatic <em>Pteropus</em> fruit bats, Henipaviruses periodically spill over into humans via intermediate hosts, causing outbreaks characterized by acute respiratory and neurological syndromes and high fatality rates. Despite the increasing frequency of spillover events linked to environmental disruptions, no licensed antivirals or human vaccines currently exist. This review summarizes recent advances in Henipavirus virology, pathogenesis, host interactions, and the innate immune evasion mechanisms. An integrated understanding of these key aspects is critical for the design of effective preventive strategies within a unified One Health approach.</div></div>","PeriodicalId":11082,"journal":{"name":"Current opinion in virology","volume":"74 ","pages":"Article 101509"},"PeriodicalIF":5.1,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146022954","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Clinical and mechanistic insights into Brucella and viral co-infection","authors":"Shi-Yang Tian , Xin Wu","doi":"10.1016/j.coviro.2025.101506","DOIUrl":"10.1016/j.coviro.2025.101506","url":null,"abstract":"<div><div>Co-infection of <em>Brucella</em> and viruses represents an emerging clinical and epidemiological challenge. Recent evidence reveals that <em>Brucella</em>-viral co-infections are characterized by atypical clinical manifestations and increased diagnostic complexity. These dual infections involve intricate pathogen–host and pathogen–pathogen interactions: viruses enhance <em>Brucella</em> susceptibility by subverting innate and adaptive immune responses, while <em>Brucella</em> compromises host immunity to create a permissive microenvironment for viral persistence. Furthermore, co-infection synergistically exacerbates tissue damage, elevating disease severity. This review summarizes recently reported cases of <em>Brucella</em>-virus co-infections and their pathogenic mechanisms, aiming to advance our understanding of co-infection dynamics and provide foundational insights for elucidating pathogenesis and developing novel diagnostic and therapeutic approaches.</div></div>","PeriodicalId":11082,"journal":{"name":"Current opinion in virology","volume":"74 ","pages":"Article 101506"},"PeriodicalIF":5.1,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145773775","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"A storm is born: immune activation and pathogenesis in arthritogenic alphavirus infections","authors":"Wesley Freppel , Yong Qian Koo , Lara J Herrero","doi":"10.1016/j.coviro.2025.101498","DOIUrl":"10.1016/j.coviro.2025.101498","url":null,"abstract":"<div><div>Arthritogenic alphaviruses, including chikungunya (CHIKV), Ross River, and Mayaro viruses, are emerging global viruses responsible for causing arthralgia and chronic arthritis. Following mosquito-borne transmission, they quickly initiate infection in the skin, including in resident immune cells, and disseminate systemically into musculoskeletal tissues. The innate immune system responds rapidly through the activation of interferons, the production of inflammatory cytokines, and the recruitment of monocytes, macrophages, neutrophils, and dendritic cells, while the adaptive immune response, particularly virus-specific T and B cells, is critical for viral clearance. However, excessive immune activation can lead to both acute and chronic musculoskeletal pain through cytokine storm, tissue damage, and supporting immunopathology. Additionally, viral persistence and immune evasion may contribute to the development of chronic synovitis and cartilage degradation, leading to persistent joint pain. Despite recent advances, antiviral treatments remain unavailable, and to date, there is only one vaccine licensed (VIMKUNYA™ in 2025, against CHIKV), underscoring the urgent need for further research. This review explores the complex interplay between host immune responses and viral factors that lead from acute infection to chronic inflammation. Furthermore, it highlights key gaps in understanding viral persistence and immune evasion, and how to predict chronic diseases to improve therapeutic and preventive strategies against arthritogenic alphaviruses.</div></div>","PeriodicalId":11082,"journal":{"name":"Current opinion in virology","volume":"74 ","pages":"Article 101498"},"PeriodicalIF":5.1,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145615757","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}